A mathematical framework to quantify the masking effect associated with the confidence intervals of measures of disproportionality

François Maignen, Manfred Hauben, Jean Michel Dogné

Résultats de recherche: Contribution à un journal/une revueArticle

Résumé

Background: The lower bound of the 95% confidence interval of measures of disproportionality (Lower95CI) is widely used in signal detection. Masking is a statistical issue by which true signals of disproportionate reporting are hidden by the presence of other medicines. The primary objective of our study is to develop and validate a mathematical framework for assessing the masking effect of Lower95CI. Methods: We have developed our new algorithm based on the masking ratio (MR) developed for the measures of disproportionality. A MR for the Lower95CI (MRCI) is proposed. A simulation study to validate this algorithm was also conducted. Results: We have established the existence of a very close mathematical relation between MR and MRCI. For a given drug–event pair, the same product will be responsible for the highest masking effect with the measure of disproportionality and its Lower95CI. The extent of masking is likely to be very similar across the two methods. An important proportion of identical drug–event associations affected by the presence of an important masking effect is revealed by the unmasking exercise, whether the proportional reporting ratio (PRR) or its confidence interval are used. Conclusion: The detection of the masking effect of Lower95CI can be automated. The real benefits of this unmasking in terms of new true-positive signals (rate of true-positive/false-positive) or time gained by the revealing of signals using this method have not been fully assessed. These benefits should be demonstrated in the context of prospective studies.

langueAnglais
Pages231-244
Nombre de pages14
journalTherapeutic Advances in Drug Safety
Volume8
Numéro7
Les DOIs
étatPublié - 1 juil. 2017

Empreinte digitale

Confidence Intervals
Pharmaceutical Preparations
Prospective Studies

mots-clés

    Citer ceci

    @article{5c321d0c21134fe194ce058d06d364c4,
    title = "A mathematical framework to quantify the masking effect associated with the confidence intervals of measures of disproportionality",
    abstract = "Background: The lower bound of the 95{\%} confidence interval of measures of disproportionality (Lower95CI) is widely used in signal detection. Masking is a statistical issue by which true signals of disproportionate reporting are hidden by the presence of other medicines. The primary objective of our study is to develop and validate a mathematical framework for assessing the masking effect of Lower95CI. Methods: We have developed our new algorithm based on the masking ratio (MR) developed for the measures of disproportionality. A MR for the Lower95CI (MRCI) is proposed. A simulation study to validate this algorithm was also conducted. Results: We have established the existence of a very close mathematical relation between MR and MRCI. For a given drug–event pair, the same product will be responsible for the highest masking effect with the measure of disproportionality and its Lower95CI. The extent of masking is likely to be very similar across the two methods. An important proportion of identical drug–event associations affected by the presence of an important masking effect is revealed by the unmasking exercise, whether the proportional reporting ratio (PRR) or its confidence interval are used. Conclusion: The detection of the masking effect of Lower95CI can be automated. The real benefits of this unmasking in terms of new true-positive signals (rate of true-positive/false-positive) or time gained by the revealing of signals using this method have not been fully assessed. These benefits should be demonstrated in the context of prospective studies.",
    keywords = "adverse drug reactions reporting systems, masking, pharmacovigilance, postmarketing, product surveillance, signal, signal detection",
    author = "Fran{\cc}ois Maignen and Manfred Hauben and Dogn{\'e}, {Jean Michel}",
    year = "2017",
    month = "7",
    day = "1",
    doi = "10.1177/2042098617704143",
    language = "English",
    volume = "8",
    pages = "231--244",
    journal = "Therapeutic Advances in Drug Safety",
    issn = "2042-0986",
    publisher = "SAGE Publications Ltd",
    number = "7",

    }

    A mathematical framework to quantify the masking effect associated with the confidence intervals of measures of disproportionality. / Maignen, François; Hauben, Manfred; Dogné, Jean Michel.

    Dans: Therapeutic Advances in Drug Safety, Vol 8, Numéro 7, 01.07.2017, p. 231-244.

    Résultats de recherche: Contribution à un journal/une revueArticle

    TY - JOUR

    T1 - A mathematical framework to quantify the masking effect associated with the confidence intervals of measures of disproportionality

    AU - Maignen,François

    AU - Hauben,Manfred

    AU - Dogné,Jean Michel

    PY - 2017/7/1

    Y1 - 2017/7/1

    N2 - Background: The lower bound of the 95% confidence interval of measures of disproportionality (Lower95CI) is widely used in signal detection. Masking is a statistical issue by which true signals of disproportionate reporting are hidden by the presence of other medicines. The primary objective of our study is to develop and validate a mathematical framework for assessing the masking effect of Lower95CI. Methods: We have developed our new algorithm based on the masking ratio (MR) developed for the measures of disproportionality. A MR for the Lower95CI (MRCI) is proposed. A simulation study to validate this algorithm was also conducted. Results: We have established the existence of a very close mathematical relation between MR and MRCI. For a given drug–event pair, the same product will be responsible for the highest masking effect with the measure of disproportionality and its Lower95CI. The extent of masking is likely to be very similar across the two methods. An important proportion of identical drug–event associations affected by the presence of an important masking effect is revealed by the unmasking exercise, whether the proportional reporting ratio (PRR) or its confidence interval are used. Conclusion: The detection of the masking effect of Lower95CI can be automated. The real benefits of this unmasking in terms of new true-positive signals (rate of true-positive/false-positive) or time gained by the revealing of signals using this method have not been fully assessed. These benefits should be demonstrated in the context of prospective studies.

    AB - Background: The lower bound of the 95% confidence interval of measures of disproportionality (Lower95CI) is widely used in signal detection. Masking is a statistical issue by which true signals of disproportionate reporting are hidden by the presence of other medicines. The primary objective of our study is to develop and validate a mathematical framework for assessing the masking effect of Lower95CI. Methods: We have developed our new algorithm based on the masking ratio (MR) developed for the measures of disproportionality. A MR for the Lower95CI (MRCI) is proposed. A simulation study to validate this algorithm was also conducted. Results: We have established the existence of a very close mathematical relation between MR and MRCI. For a given drug–event pair, the same product will be responsible for the highest masking effect with the measure of disproportionality and its Lower95CI. The extent of masking is likely to be very similar across the two methods. An important proportion of identical drug–event associations affected by the presence of an important masking effect is revealed by the unmasking exercise, whether the proportional reporting ratio (PRR) or its confidence interval are used. Conclusion: The detection of the masking effect of Lower95CI can be automated. The real benefits of this unmasking in terms of new true-positive signals (rate of true-positive/false-positive) or time gained by the revealing of signals using this method have not been fully assessed. These benefits should be demonstrated in the context of prospective studies.

    KW - adverse drug reactions reporting systems

    KW - masking

    KW - pharmacovigilance

    KW - postmarketing

    KW - product surveillance

    KW - signal

    KW - signal detection

    UR - http://www.scopus.com/inward/record.url?scp=85021128530&partnerID=8YFLogxK

    U2 - 10.1177/2042098617704143

    DO - 10.1177/2042098617704143

    M3 - Article

    VL - 8

    SP - 231

    EP - 244

    JO - Therapeutic Advances in Drug Safety

    T2 - Therapeutic Advances in Drug Safety

    JF - Therapeutic Advances in Drug Safety

    SN - 2042-0986

    IS - 7

    ER -